Developing a novel anti-leukemic therapy through the combination of proteasome inhibitors and chimeric antigen receptor (CAR) expressing natural killer cells
Saved in:
| Main Author: | |
|---|---|
| Format: | Book/Monograph Thesis |
| Language: | English |
| Published: |
Heidelberg
2024
|
| Subjects: | |
| Online Access: |
|
| Author Notes: | vorgelegt von David Nikolov Sedloev ; Doktorvater: Prof. Dr. med. Michael Schmitt |
| Description not available. |